The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYSL.L Regulatory News (MYSL)

  • There is currently no data for MYSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) MySale Group PLC

5 Jul 2019 17:00

RNS Number : 7015E
MySale Group PLC
05 July 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MySale Group plc ("MySale")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MySale

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

5 July 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 10 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The directors of MySale have the following interests in MySale:

 

Name

No. of ordinary shares held

% of ordinary issued share capital

Jamie Jackson

47,469,189

31.4%

Carl Jackson

3,745,000

2.5%

Charles Butler

17,000

0.0%

David Mortimer AO

165,000

0.1%

 

The directors of the Company have the following rights to subscribe for the following relevant MySale securities:

 

Name

Plan

Date of grant

Options price (pence)

No. of options outstanding

Carl Jackson

Loan Share Plan

14 June 2014

2.26

111,499

 

The Company's employee benefit trust ("EBT"), of which MySale Group Trustee Limited (the "Trustee") is trustee, holds 3,000,000 ordinary shares in the Company. Carl Jackson and Jamie Jackson are the directors of the Trustee. Ordinary shares held by the EBT are unable to be voted, in line with the EBT's rules.

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 July 2019

Contact name:

CARL JACKSON

Telephone number:

+61(02)91198950

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEEELFBKDFEBBZ
Date   Source Headline
20th May 20194:55 pmRNSHolding(s) in Company
16th May 20197:00 amRNSDisposal
3rd May 20197:00 amRNSDisposal
26th Mar 20197:01 amRNSChange of Nomad
26th Mar 20197:00 amRNSHalf Year Results
12th Mar 20197:00 amRNSNotice of Results
8th Feb 20197:00 amRNSPre-close Trading Update
11th Dec 20184:40 pmRNSSecond Price Monitoring Extn
11th Dec 20184:35 pmRNSPrice Monitoring Extension
11th Dec 20187:00 amRNSTrading Update
3rd Dec 20181:42 pmRNSResult of AGM and Directorate Change
20th Nov 20184:16 pmRNSHolding(s) in Company
15th Nov 20187:00 amRNSDirectorate Change
12th Nov 201812:00 pmRNSAnnual Financial Report
12th Oct 20182:52 pmRNSHolding(s) in Company
11th Oct 20189:50 amRNSHolding(s) in Company
9th Oct 20187:01 amRNSDirectorate Change
9th Oct 20187:00 amRNSPreliminary Results
7th Sep 20183:00 pmRNSNotice of Results
10th Jul 20187:03 amRNSPre-Close Trading Update
12th Jun 201812:45 pmRNSHolding(s) in Company
5th Mar 20187:00 amRNSHalf Year Results
27th Feb 20184:15 pmRNSNotice of Results
25th Jan 20187:00 amRNSTrading Update
6th Dec 20179:17 amRNSResult of AGM
4th Dec 20177:41 amRNSAGM Update
20th Nov 20179:00 amRNSPublication of Annual Report and Notice of AGM
31st Oct 20177:00 amRNSNon-Executive Director Appointment
26th Sep 20177:00 amRNSPreliminary Results
26th Jul 20177:00 amRNSPre-close Trading Update
11th Apr 201711:57 amRNSHolding(s) in Company
6th Apr 20177:00 amRNSAcquisition
4th Apr 201710:07 amRNSHolding(s) in Company
4th Apr 201710:04 amRNSHolding(s) in Company
1st Mar 20177:00 amRNSHalf-year Report
31st Jan 20179:15 amRNSIssue of Equity
20th Jan 20177:00 amRNSPre-Close Trading Update
2nd Dec 20165:08 pmRNSHolding(s) in Company
2nd Dec 20168:36 amRNSHolding(s) in Company
30th Nov 20164:43 pmRNSHolding(s) in Company
29th Nov 201611:59 amRNSResult of AGM
29th Nov 20167:00 amRNSAGM Statement
8th Nov 201610:26 amRNSPublication of Annual Report and Notice of AGM
26th Oct 201611:49 amRNSHolding(s) in Company
24th Oct 20165:27 pmRNSHolding(s) in Company
20th Oct 20163:28 pmRNSHolding(s) in Company
28th Sep 20167:00 amRNSPreliminary Results
9th Sep 20169:00 amRNSNotice of Results
21st Jul 20167:01 amRNSAppointment of Joint Corporate Broker
21st Jul 20167:00 amRNSPre-close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.